Publications by authors named "Stacey Fernandes"

Claim this Profile
N
Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies.
Binu Kandathilparambil Sasi, Chiara Tarantelli, Stephen Martindale, Elisa Civanelli, Eleonora Cannas, Stacey M Fernandes

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare germline variant in NFATC4 associated with familial CLL.
Gilad Itchaki, Harrison Bai, Grace Tiao, Reina Improgo, Ben E Oppenheimer, Stacey M Fernandes

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukemia often arises by a multiclonal selection process.
Davide Bagnara, Andrea N Mazzarello, Niccolò Cardente, Stefano Vergani, Siddha Kasar, Stacey Fernandes

Haematologica· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia.
Kiyomi Mashima, Yanan Kuang, Stacey M Fernandes, Shidong Xu, Benjamin Hanna

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, Daniel S Choi, Stacey M Fernandes

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the influence of germline variants in chronic lymphocytic leukemia on cancer vulnerability.
Roberta S Azevedo, Francesca Morelli, Kiyomi Mashima, Rayan Fardoun, Svitlana Tyekucheva, Stacey Fernandes

Haematologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Stacey M Fernandes

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Stacey M Fernandes

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia.
Stephen Jun Fei Chong, Junyan Lu, Rebecca Valentin, Timothy Z Lehmberg, Jie Qing Eu, Stacey M Fernandes

Mol Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of sampling method and season on modeling of selenium into coldwater fish and implications on tissue-based water quality benchmarks.
Maíra Peixoto Mendes, Beatriz Cupe-Flores, Katherine Woolhouse, Stacey Fernandes, Karsten Liber

Integr Environ Assess Manag· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia.
Abi Vijenthira, Virginia O Volpe, Aswin Sekar, Roberta Santos Azevedo, Mariia Mikhaleva, Stacey M Fernandes

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.
Laura Ondrisova, Vaclav Seda, Krystof Hlavac, Petra Pavelkova, Eva Hoferkova, Stacey M Fernandes

J Clin Invest· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assaying and classifying T cell function by cell morphology.
Xin Wang, Stacey M Fernandes, Jennifer R Brown, Lance C Kam

BioMedInformatics· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations Detected in Real World Clinical Sequencing during BTK Inhibitor Treatment in CLL.
Jennifer Brown, Kiyomi Mashima, Stacey Fernandes, Aishath Naeem, Samantha Shupe

Res Sq· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples.
Jasneet Kaur Khalsa, Justin Cha, Filippo Utro, Aishath Naeem, Ishwarya Murali, Stacey M Fernandes

Blood· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance.
Aishath Naeem, Filippo Utro, Qing Wang, Justin Cha, Mauno Vihinen, Stacey M Fernandes

Blood Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.
Yiming Wu, Meiling Jin, Mike Fernandez, Kevyn L Hart, Aijun Liao, Stacey M Fernandes

Blood Cancer Discov· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia.
Christine E Ryan, Danielle M Brander, Paul M Barr, Svitlana Tyekucheva, Liam R Hackett, Stacey M Fernandes

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Germline Variants Influence the Development of Chronic Lymphocytic Leukemia.
Benjamin L Lampson, Aditi Gupta, Svitlana Tyekucheva, Kiyomi Mashima, Anna Petráčková, Stacey M Fernandes

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors.
Deepti Gadi, Stephen P Martindale, Pui Yan Chiu, Jasneet Khalsa, Pei-Hsuan Chen, Stacey M Fernandes

Blood Cancer J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
Erin M Parry, Ignaty Leshchiner, Romain Guièze, Connor Johnson, Eugen Tausch, Stacey M Fernandes

Nat Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular map of chronic lymphocytic leukemia and its impact on outcome.
Binyamin A Knisbacher, Ziao Lin, Cynthia K Hahn, Ferran Nadeu, Martí Duran-Ferrer, Stacey M Fernandes

Nat Genet· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia.
Yanping Yin, Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Stacey M Fernandes

Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib activates AKT via increased recruitment of PI3Kδ/PI3Kβ to BCR signalosome while reducing PDK1 in post-therapy CLL cells.
Murali K Mamidi, Hasan Mahmud, Guru P Maiti, Mariana T Mendez, Stacey M Fernandes

Leukemia· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia.
Deepti Gadi, Alec Griffith, Zixu Wang, Svitlana Tyekucheva, Vanessa Rai, Stacey M Fernandes

Br J Haematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis